Ovia Health Named Top Women's Health IT Vendor by Employers and Payers at AHIP 25, Black Book Research Reports

June 16, 2025 12:15 PM

Ovia Health, a Labcorp company providing comprehensive fertility, maternity, and parental health solutions, has been recognized as the top-rated Women's Health IT vendor by Black Book Research at AHIP 25. This acknowledgment is based on unbiased feedback collected from a collective pool of 305 employers, payers, and health system clients.Black Book's rigorous evaluation process measured vendors against key qualitative performance indicators...

Read more

Sagility Named Top-Rated Vendor for Outsourced Claims Adjudication and Payer Customer Service by Black Book Research at AHIP 25

June 16, 2025 11:45 AM

According to Black Book's Q2 2025 survey of 571 health plan executives, 91% reported plans to increase or maintain outsourcing partnerships for claims and customer service operations through 2026, citing rising regulatory complexity, AI integration demands, and internal cost containment pressures as top drivers. EIghty-four percent of those surveyed identified automation maturity and seamless system interoperability as essential attributes when...

Read more

Elite Surgeons Join Defyne MD, Solidifying Scottsdale as a National Destination for Cutting-Edge Aesthetic Care

June 16, 2025 11:15 AM

In a bold move that positions Scottsdale as a national epicenter of regenerative and aesthetic medicine, Defyne MD, the boundary-pushing boutique practice founded by acclaimed plastic and reconstructive microsurgeon Dr. Oren Tessler, MD, announces a significant expansion-both in talent and technology. The practice has welcomed four elite surgeons to its team and launched the Southwest's first fat banking clinic, ushering in a new era of...

Read more

Top-Ranked Health Tech Startups Revealed in Investor and Analyst Survey Ahead of HLTH Europe 2025 by Black Book Research

June 16, 2025 10:30 AM

Amid hundreds of health technology startups exhibiting at HLTH Europe 2025, Black Book Research has revealed the most promising European healthcare IT firms selected by investors for their superior growth potential, regulatory preparedness, and ability to scale across diverse health systems. Based on a rigorous evaluation by 407 venture capitalists, private equity analysts, and investment bankers, these startups achieved the highest scores...

Read more

I-MAK Report Reveals How Extending Patent Terms Inflates Prices of Medicare's Top Negotiated Drugs

June 16, 2025 10:00 AM

The Initiative for Medicines, Access, and Knowledge (I-MAK) published the latest data brief in its landmark Overpatented, Overpriced series, revealing the multiple ways pharmaceutical companies are able to extend their patent protection and keep drug prices high. The new data brief exposes how these systemic flaws impact Eliquis, a top-selling blood thinner, and the semaglutide family of diabetes and weight-loss drugs including Ozempic,...

Read more

Mann Eye Institute First in Texas to Offer NextLevel LASIK Technology

June 16, 2025 10:00 AM

Mann Eye Institute, a pioneering leader in vision correction for over three decades, today announced it is the first practice in Texas and third in the nation to offer NextLevel LASIK powered by the revolutionary Wavelight Plus system. This groundbreaking technology delivers unprecedented visual outcomes that surpass traditional LASIK results and is now available at both the institute's Houston and Austin locations.Mann Eye Institute's...

Read more

Health Plan Executives at AHIP 2025 Align Strongly on Value-Based Reimbursement Optimization as Top IT Priority, Black Book Survey Finds

June 16, 2025 9:30 AM

In the lead-up to AHIP 2025, a national survey conducted by Black Book Research reveals that an overwhelming majority of attending payer executives and health plan leaders have identified Value-Based Reimbursement Optimization (VBRO) as their organization's top strategic IT focus in 2025.The survey, conducted across 849 managed care executives, half of whom are AHIP 2025 attendees, highlights how rapidly accelerating federal and state mandates...

Read more

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

June 16, 2025 9:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will resume a regular quarterly investor call schedule, beginning with the release of its fiscal third quarter 2025 financial results in mid-August 2025. In alignment with this resumption, the Company has cancelled its previously scheduled intra-quarter investor call for June 17, 2025.About Applied DNA...

Read more

1933 Industries Reports Profit in Third Quarter 2025 Financial Results

June 16, 2025 8:50 AM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its third quarter financial results ("Q3 2025") for the three and nine months ended April 30, 2025 and 2024 ("Fiscal 2025"). All amounts expressed are in Canadian dollars.The Company owns 100%1 of Alternative Medicine Association (AMA), the Company's cultivation and production subsidiary...

Read more

Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions

June 16, 2025 8:00 AM

Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, is pleased to announce its participation in the American Diabetes Association ("ADA") 85th Scientific Sessions, taking place June 20-23, 2025, at the McCormick Place Convention Center in...

Read more

Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy

June 16, 2025 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today issued a mid-year update outlining key strategic milestones achieved during the first half of 2025. The Company has transitioned from R&D to commercial execution, marked by its first AI Nose-driven revenue, expanded industry partnerships, and regulatory approval for its lead VELDONA human drug candidates to enter clinical trials. These developments position Ainos to launch...

Read more

Allied OMS Announces Strategic Growth Investment from 65 Equity Partners

June 16, 2025 3:00 AM

Allied OMS, a doctor-led management services organization (MSO) supporting premier oral and maxillofacial surgery practices across the United States, is pleased to announce it has received a significant minority investment from 65 Equity Partners, a global investment firm dedicated to supporting family-owned businesses, founders, and entrepreneurs. Everberg Capital, a private capital investment firm, will also co-invest alongside 65 Equity...

Read more

Notice To Extraordinary General Meeting In Alzecure Pharma AB

June 16, 2025 2:30 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - The shareholders of AlzeCure Pharma AB are hereby summoned to an extraordinary general meeting to be held on Wednesday 2 July 2025 at 15:30 CEST at the offices of Synch Advokat, Birger Jarlsgatan 6, Stockholm.NOTIFICATION ETC.Shareholders who wish to participate in the general meeting must• be entered as a shareholder in the share register maintained by Euroclear Sweden AB on Tuesday 24 June 2025; and•...

Read more

AlzeCure Carries out a Rights Issue of Approximately SEK 48.5 million

June 16, 2025 2:20 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB ("AlzeCure" or the "Company"), a pharmaceutical company that develops a broad portfolio of small molecule drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announces that the Board of Directors has resolved on a new share issue of approximately SEK 48.5[1] million with preferential rights for existing shareholders...

Read more

Black Book Research Names 18 European Healthcare IT Startups to Watch at HLTH Europe 2025

June 15, 2025 10:45 AM

Black Book, the independent healthcare IT research firm, today unveiled a critical resource designed specifically for investors, technology decision-makers, and media professionals ahead of the HLTH Europe 2025 event in Amsterdam. This guide, based on rigorous evaluations from 407 leading European investors including venture capitalists, private equity analysts, and investment bankers, pinpoints the top healthcare IT startups that demonstrate...

Read more

ProDentim Reviews Consumer Reports (2025 June) How It Works, What It Costs, and Real User Feedback

June 15, 2025 7:30 AM

ProDentim is a dental health supplement formulated to support strong teeth and healthy gums. According to the makers of this product, it's built on cutting-edge research highlighting the crucial role of the oral microbiome. The formula features a unique blend of probiotics aimed at restoring balance in the mouth and promoting a healthier oral environment. With all the recent buzz around ProDentim, it's only natural to wonder if the hype is truly...

Read more

Why the Future of Wellness Lies in Cellular Health: Total Health Revive Makes the Case for a New Standard in Healing

June 15, 2025 7:25 AM

In a health landscape saturated with band-aid solutions, reactive care models, and a pharmaceutical-first mindset, one wellness organization is boldly shifting the narrative. Total Health Revive (THR), founded by functional medicine pioneer Dr. Brian Anderson, is challenging conventional thinking by advocating a concept that could very well redefine the future of health: cellular revitalization.Modern healthcare is obsessed with symptoms. You...

Read more

ProstaVive Reviews (Consumer Reports & Complaints) Ingredients, Real User Results, Pros and Cons! (INVESTIGATED)

June 15, 2025 7:09 AM

ProstaVive is a newly launched dietary supplement developed to support prostate function and overall male health. According to the makers, this fast-acting, plant-based formula is designed to promote better urinary flow and bladder control-two common concerns for men as they age. Statistics from the National Institutes of Health highlight how widespread prostate-related issues have become, with conditions like benign prostatic hyperplasia (BPH)...

Read more

DEA Delays MMJ Cannabis Research While Allowing Texas Ibogaine Studies Without Obstruction: The Tale of Two Schedule I Substances

June 15, 2025 5:00 AM

The Drug Enforcement Administration (DEA) has spent the last seven years obstructing MMJ BioPharma Cultivation's federally lawful efforts to research cannabis derived medicine for devastating neurological diseases. Yet this week, the same Drug Enforcement Administration sits idly by as Texas Governor Greg Abbott signs SB 2308, a bold new law investing $50 million into clinical research of ibogaine, a Schedule I psychedelic with no FDA approval...

Read more

Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers

June 13, 2025 6:00 PM

Onco-Innovations Limited (CBOE:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into an agreement with the University of Alberta and Cross Cancer Institute to undertake a preclinical study that supports the Company's intention to expand the research scope of its second-generation nanoparticle formulation of its Polynucleotide Kinase 3'-Phosphatase (PNKP) Inhibitor technology to encompass...

Read more